Visium Technologies corrects claim CFO extended cure period before original filing

• Visium Technologies corrected its October 30, 2026, disclosure: Mark B. Lucky had not extended the cure period for his Good Reason notice.
• Lucky's November 2 letter suspended the cure period pending an independent committee; the period ends 30 days after that committee is constituted.
• His Good Reason resignation takes effect no later than March 1, 2027, if unresolved; Lucky has not resigned.
• Responding to former CEO Paul R. Taylor, the company reiterated its board had not concluded previously issued financial statements were unreliable.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Visium Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001654954-26-009481), on November 03, 2026, and is solely responsible for the information contained therein.